ACE2 and COVID-19: Studies have shown that angiotensin-converting enzyme 2 (ACE2), the receptor for SARS-CoV-2, is more highly expressed in adipose tissue than in lung tissue and may be associated with the progression of severe COVID-19 in obese patients [38].